Kyriakides worked in the Ministry of Health between 1976 and 2006, as a clinical psychologist in the department of Child and Adolescent psychiatry.[3]
In 1999 Kyriakides was elected as president of the First Breast Cancer Movement in Cyprus.[4][5] From 2004 until 2006, she served as president of the European Breast Cancer Coalition Europa Donna. In 2016, she was appointed President of the National Committee on Cancer Strategy of the Council. Stella Kyriakides was also recognized as one of the 100 Influential Women in Oncology by OncoDaily.[6]
In 2018, Kyriakides pushed for a law decriminalizing abortion in Cyprus.[9]
Council of Europe
In addition to her parliamentary duties in Cyprus, from 2012 until 2019 Kyriakides served as the chairperson of the Cyprus delegation to the Parliamentary Assembly of the Council of Europe (PACE). From 2016 until 2018, she chaired the PACE Committee on Social Affairs, Health, and Regional Development. In October 2017, after the resignation of the Spanish member Pedro Agramunt, she ran for the presidency of the PACE, winning the voting in the third round against the Lithuanian Emanuelis Zingeris.[10][4] From 2018 until 2019, she served as the PACE representative to the Venice Commission.
Following the 2024 European elections, Kyriakides announced that she would not be available for another term and instead expressed her intention to return to Cyprus.[14]
Vaccination procurement during COVID-19 pandemic
Kyriakides came under attack by the international media and the public as her procurement of COVID-19 vaccines was said to be slow and insufficient,[15][16][17] especially in comparison to the United States and the United Kingdom.[17]AstraZeneca's CEO, Soriot, blamed the EU for being three months slower than the U.K. in finalizing its purchase agreements for the vaccine, which AstraZeneca had developed.[18]
According to the German tabloid newspaper Bild-Zeitung, Germany’s Health Minister Jens Spahn had warned Chancellor Angela Merkel about Kyriakides’ slow response time.[19] However, Kyriakides rejected all criticism and defended the EU joint procurement strategy, claiming that it had "medical and social virtues".[20] She also rejected the logic of "first come, first served,", arguing "that may work at the neighborhood butcher’s but not in contracts."[21] AstraZeneca hit back, stating that the contract only included 'best efforts' to supply the EU commission, whereas the UK contract included provisions to supply the entirety of the UK from the company’s British plants first, before allowing export overseas.[22]
Personal life
Kyriakides has two children. She had breast cancer in 1996 and 2004.[2]